22 May 2013
Keywords: zeneca, zomig, approved, additional, countries, pharmaceuticals, been
Article | 18 August 1997
- Zeneca Pharmaceuticals has been granted clearance to market its5-HT1B/1D receptor antagonist Zomig (zolmitriptan) in Germany, Denmark and ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.